Recombinant multi-species MSI2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MSI2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes an RNA-binding protein that is a member of the Musashi protein family. The encoded protein is transcriptional regulator that targets genes involved in development and cell cycle regulation. Mutations in this gene are associated with poor prognosis in certain types of cancers. This gene has also been shown to be rearranged in certain cancer cells. [provided by RefSeq, Apr 2016]
The Alternative Names of target: 1700105C15Rik,MSI2,MSI2H,Msi2,Msi2h,Musashi-2,RGD1560397,RNA-binding protein Musashi homolog 2

Target products collectionGo to MSI2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T35817-Ag-1/ GM-Tg-hg-T35817-Ag-2 Human MSI2 protein Human
GM-Tg-rg-T35817-Ag-1/ GM-Tg-rg-T35817-Ag-2 Rat MSI2 protein Rat
GM-Tg-mg-T35817-Ag-1/ GM-Tg-mg-T35817-Ag-2 Mouse MSI2 protein Mouse
GM-Tg-cynog-T35817-Ag-1/ GM-Tg-cynog-T35817-Ag-2 Cynomolgus/Rhesus macaque MSI2 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T35817-Ag-1/ GM-Tg-felg-T35817-Ag-2 Feline MSI2 protein Feline
GM-Tg-cang-T35817-Ag-1/ GM-Tg-cang-T35817-Ag-2 Canine MSI2 protein Canine
GM-Tg-bovg-T35817-Ag-1/ GM-Tg-bovg-T35817-Ag-2 Bovine MSI2 protein Bovine
GM-Tg-equg-T35817-Ag-1/ GM-Tg-equg-T35817-Ag-2 Equine MSI2 protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T35817-Ag-1/ GM-Tg-hg-T35817-Ag-2; GM-Tg-rg-T35817-Ag-1/ GM-Tg-rg-T35817-Ag-2;
GM-Tg-mg-T35817-Ag-1/ GM-Tg-mg-T35817-Ag-2; GM-Tg-cynog-T35817-Ag-1/ GM-Tg-cynog-T35817-Ag-2;
GM-Tg-felg-T35817-Ag-1/ GM-Tg-felg-T35817-Ag-2; GM-Tg-cang-T35817-Ag-1/ GM-Tg-cang-T35817-Ag-2;
GM-Tg-bovg-T35817-Ag-1/ GM-Tg-bovg-T35817-Ag-2; GM-Tg-equg-T35817-Ag-1/ GM-Tg-equg-T35817-Ag-2
Products Name MSI2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name MSI2
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MSI2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.